Get started
EPISURF MEDICAL AB BEPISURF MEDICAL AB BEPISURF MEDICAL AB B

EPISURF MEDICAL AB B

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Seasonals

16E chart


Full chart

Key stats


Market capitalization
‪6.92 M‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.0182 EUR
Net income (FY)
‪−8.48 M‬ EUR
Revenue (FY)
‪921.06 K‬ EUR
Shares float
‪646.72 M‬
Beta (1Y)
0.21

About EPISURF MEDICAL AB B


Sector
Health Technology
Industry
Medical Specialties
CEO
Pål Ryfors
Website
episurf.com
Headquarters
Stockholm
Founded
2008
ISIN
SE0003491562
FIGI
BBG00LNDVWG7
Episurf Medical AB engages in patient-specific technology for the treatment of painful joint injuries. It provides solutions composing of individual implant, surgical drill guides, and patient specific surgical planning and design. The company's brands include episealer, epiguide, and µifidelity system. Episurf Medical was founded in January 2009 and is headquartered in Stockholm, Sweden.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

16E news



Ideas



See all ideas 

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange EPISURF MEDICAL AB B stocks are traded under the ticker 16E.
16E reached its all-time high on Oct 27, 2021 with the price of 0.5540 EUR, and its all-time low was 0.0001 EUR and was reached on Jun 28, 2024. View more price dynamics on 16E chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track EPISURF MEDICAL AB B financials in yearly and quarterly reports right on TradingView.
EPISURF MEDICAL AB B revenue for the last quarter amounts to ‪299.26 K‬ EUR, despite the estimated figure of ‪536.91 K‬ EUR. In the next quarter, revenue is expected to reach ‪305.05 K‬ EUR.
16E net income for the last quarter is ‪−1.40 M‬ EUR, while the quarter before that showed ‪−1.88 M‬ EUR of net income which accounts for 25.40% change. Track more EPISURF MEDICAL AB B financial stats to get the full picture.
No, 16E doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 22, 2024, the company has 28.00 employees. See our rating of the largest employees — is EPISURF MEDICAL AB B on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. EPISURF MEDICAL AB B EBITDA is ‪−6.65 M‬ EUR, and current EBITDA margin is −881.55%. See more stats in EPISURF MEDICAL AB B financial statements.
Like other stocks, 16E shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade EPISURF MEDICAL AB B stock right from TradingView charts — choose your broker and connect to your account.